Avricore Health Inc. (TSXV:AVCR)

Market Cap	8.85M +24.8%
Revenue (ttm)	193.04K -93.7%
Net Income	-1.80M
EPS	-0.02
Shares Out	126.37M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,000
Open	0.0700
Previous Close	0.0700
Day's Range	0.0700 - 0.0700
52-Week Range	0.0450 - 0.1000
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 2, 2026

About Avricore Health

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1996
• Employees: 26
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: AVCR

Financial Performance

In 2025, Avricore Health's revenue was 533,884, a decrease of -88.84% compared to the previous year's 4.79 million. Losses were -1.86 million, 177.8% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 4, 2026

Data Sources Report a data error